Forian Inc
NASDAQ:FORA

Watchlist Manager
Forian Inc Logo
Forian Inc
NASDAQ:FORA
Watchlist
Price: 2.145 USD -1.61% Market Closed
Market Cap: 66.6m USD

Forian Inc
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Forian Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Forian Inc
NASDAQ:FORA
Gross Profit
$15.6m
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Gross Profit
$2.3B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
25%
Inspire Medical Systems Inc
NYSE:INSP
Gross Profit
$749.5m
CAGR 3-Years
37%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Gross Profit
$514.5m
CAGR 3-Years
19%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Gross Profit
$516m
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
8%
W
Waystar Holding Corp
NASDAQ:WAY
Gross Profit
$627.8m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Forian Inc
Glance View

Market Cap
66.5m USD
Industry
Health Care

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.

FORA Intrinsic Value
2.415 USD
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Forian Inc's Gross Profit?
Gross Profit
15.6m USD

Based on the financial report for Sep 30, 2025, Forian Inc's Gross Profit amounts to 15.6m USD.

What is Forian Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
14%

Over the last year, the Gross Profit growth was 18%. The average annual Gross Profit growth rates for Forian Inc have been -2% over the past three years , 14% over the past five years .

Back to Top